| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.001 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.002 |